Kerry expands plant protein capabilities with Pevesa acquisition

Spain-based Pevesa Biotech is a specialist in rice and pea protein processing

Kerry has expanded its non-allergenic and organic plant protein capability by acquiring the Spanish company Pevesa Biotech. The acquisition enhances Kerry’s position in the hydrolysed plant protein space for specialised nutrition, and expands the company’s capacity to serve the organic plant protein market.

Based in Spain, Pevesa Biotech is a well-established player in non-allergenic, non-GMO plant proteins for the infant, general and clinical nutrition markets.

Pevesa offer a range of plant proteins, including organic pea and rice protein and protein hydrolysates and is a specialist in non-allergenic plant proteins for infant nutrition. Pevesa has also developed a range of organic and standard biofertilizers for fruit, olive and specialist garden growers, and has had a strong corporate focus for many years on developing sustainable solutions to important nutrition, health, biowaste and agricultural challenges.

John Reilly, VP of Business Development Proteins for Kerry, said: “Kerry was attracted to Pevesa because of its expertise, innovation, high-quality manufacturing leadership, and patented technology in the non-allergenic plant protein market. This will be a good fit with Kerry’s growing plant protein product portfolio, and Pevesa’s customers will benefit from the synergy between its market-leading technology and Kerry’s protein processing expertise.”

The growing inclination of consumers toward natural and plant-based products has been fueling the explosive demand for plant-based foods over the last few years. This trend extends to increased demand for plant protein sources. As consumers reduce their consumption of dairy and soya proteins (for allergy, health, sustainability or animal welfare reasons), rice and pea protein have become two of the fastest-growing plant protein segments globally.

Companies